Takuji Nakamura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Takuji Nakamura has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Akio Nakajima
B Hematology and Immunology, Kanazawa Medical University , Ishikawa , Japan
1 shared publicationHaruka Iwao
B Hematology and Immunology, Kanazawa Medical University , Ishikawa , Japan
1 shared publicationHideaki Hamano
J Medical Informatics Division and Department of Internal Medicine, Gastroenterology , Shinshu University School Hospital , Nagano , Japan
1 shared publicationHiroto Tsuboi
N Department of Internal Medicine, Faculty of Medicine , University of Tsukuba , Ibaraki , Japan
1 shared publication- Hisanori Umehara
Department of Rheumatology and Immunology, Nagahama City Hospital, Oinuicho, Nagahama, Shiga 526-0043, Japan
1 shared publication Kazuichi Okazaki
O Third Department of Internal Medicine, Division of Gastroenterology and Hepatology , Kansai Medical University , Osaka , Japan
1 shared publication
Latest Publications
- 11 July 2019
- Published by Oxford University Press (OUP) in Modern Rheumatology
- Vol. 30 (3) , 551-557
Impaired expression of innate immunity-related genes in IgG4-related disease: A possible mechanism in the pathogenesis of IgG4-RD
[Background] IgG4-related disease (IgG4-RD) is characterized by elevated serum IgG4 and tissue infiltration by IgG4-positive plasma cells. The pathogenesis of this disease is not clear. Transcriptome analysis was performed to identify genes over- and under-expressed in patients with IgG4-RD. [Method] DNA microarray analysis was performed using RNA from peripheral blood mononuclear cells of two patients with IgG4-RD and four healthy individuals. Genes showing a greater than 3-fold change in expression in IgG4-RD patients following steroid therapy were identified. Four genes related to innate immunity such as transcobalamin I (TCN1), secretory leukocyte peptidase inhibitor (SLPI), bactericidal/permeability-increasing protein (BPI) and lactotransferrin (LTF) were assessed by real-time PCR in 15 IgG4-RD patients and 13 healthy individuals. [Result] DNA microarray analysis identified 30 genes showing a greater than 3-fold change in expression in IgG4-RD patients following steroid therapy. Real-time RT-PCR showed that the levels of mRNAs encoding TCNI and SLPI, except for BPI and LTF, were significantly lower in patients with IgG4-RD than in healthy people. The levels of all four mRNAs in patients with IgG4-RD were significantly increased after steroid treatment. [Conclusion] These results indicate that reduction in expression of innate immunity-related genes may participate in the pathogenesis of IgG4-RD that steroid treatment may rectify impaired innate immunity as well as acquired immunity.
- 11 July 2019
- Published by Oxford University Press (OUP) in Modern Rheumatology
- Vol. 30 (3) , 551-557
Impaired expression of innate immunity-related genes in IgG4-related disease: A possible mechanism in the pathogenesis of IgG4-RD
[Background] IgG4-related disease (IgG4-RD) is characterized by elevated serum IgG4 and tissue infiltration by IgG4-positive plasma cells. The pathogenesis of this disease is not clear. Transcriptome analysis was performed to identify genes over- and under-expressed in patients with IgG4-RD. [Method] DNA microarray analysis was performed using RNA from peripheral blood mononuclear cells of two patients with IgG4-RD and four healthy individuals. Genes showing a greater than 3-fold change in expression in IgG4-RD patients following steroid therapy were identified. Four genes related to innate immunity such as transcobalamin I (TCN1), secretory leukocyte peptidase inhibitor (SLPI), bactericidal/permeability-increasing protein (BPI) and lactotransferrin (LTF) were assessed by real-time PCR in 15 IgG4-RD patients and 13 healthy individuals. [Result] DNA microarray analysis identified 30 genes showing a greater than 3-fold change in expression in IgG4-RD patients following steroid therapy. Real-time RT-PCR showed that the levels of mRNAs encoding TCNI and SLPI, except for BPI and LTF, were significantly lower in patients with IgG4-RD than in healthy people. The levels of all four mRNAs in patients with IgG4-RD were significantly increased after steroid treatment. [Conclusion] These results indicate that reduction in expression of innate immunity-related genes may participate in the pathogenesis of IgG4-RD that steroid treatment may rectify impaired innate immunity as well as acquired immunity.